跳至主要内容
临床试验/NCT07490132
NCT07490132招募中不适用

Endoscopic Retrograde Cholangiopancreatography Patient Registry

Methodist Health System1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Underwent ERCP

研究概览

简要总结

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

详细描述

The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025

排除标准

  • Patients <15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.

结局指标

主要结局

Underwent ERCP

时间窗: 25 years

Patients undergoing ERCPs at Methodist Dallas Medical Center.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验